High Response Rate Seen in Paediatric Oncology Patients Receiving Precision Medicine: The Starship Children's Hospital Experience

被引:0
|
作者
Naeije, L. [1 ]
Cockcroft, R. [1 ]
Laughton, S. [1 ]
Macfarlane, S. [2 ]
Winstanley, M. [1 ]
Wood, A. [1 ]
De Silva, M. [1 ]
Tsui, K. [1 ]
机构
[1] Starship Childrens Hosp, Starship Blood & Canc Ctr, Auckland, New Zealand
[2] Starship Childrens Hosp, Natl Child Canc Network, Auckland, New Zealand
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
0700
引用
收藏
页码:S315 / S315
页数:1
相关论文
共 28 条
  • [21] Direct Transfer of Pediatric Appendicitis Patients Is Associated with a High False Positive Rate Upon Referral to a Tertiary Children's Hospital Despite Increased Computed Tomography Exposure
    Grant, Matthew T.
    MacGregor, Robert M.
    Vrecenak, Jesse D.
    [J]. PEDIATRICS, 2021, 147 (03)
  • [23] Development and validation of a single-cell network profiling assay-based classifier to predict response to induction therapy in paediatric patients with de novo acute myeloid leukaemia: a report from the Children's Oncology Group
    Lacayo, Norman J.
    Alonzo, Todd A.
    Gayko, Urte
    Rosen, David B.
    Westfall, Matt
    Purvis, Norman
    Putta, Santosh
    Louie, Brent
    Hackett, James
    Cohen, Aileen Cleary
    Cesano, Alessandra
    Gerbing, Robert
    Ravindranath, Yaddanapudi
    Dahl, Gary V.
    Gamis, Alan
    Meshinchi, Soheil
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2013, 162 (02) : 250 - 262
  • [24] Tandem high-dose 131I-MIBG therapy supported by dosimetry in pediatric patients with relapsed-refractory high-risk neuroblastoma: the Bambino Gesu' Children's Hospital experience
    Altini, Claudio
    Villani, Maria F.
    Di Giannatale, Angela
    Cassano, Bartolomeo
    Pizzoferro, Milena
    Serra, Annalisa
    Castellano, Aurora
    Cannata, Vittorio
    Garganese, Maria C.
    [J]. NUCLEAR MEDICINE COMMUNICATIONS, 2022, 43 (02) : 129 - 144
  • [25] Identifying Tumor-Specific Immune Response and Biomarkers of High-Risk Hodgkin Lymphoma Patients Treated with and without Brentuximab on Children's Oncology Group Trial AHOD1331
    Toner, Keri
    Dave, Hema
    Pezzella, Gloria
    Pei, Qinglin
    Horton, Terzah M.
    Kelly, Kara M.
    Roth, Lisa Giulino
    Castellino, Sharon M.
    Bollard, Catherine M.
    [J]. BLOOD, 2023, 142
  • [26] The impact of ABCG2 C421A gene polymorphism on high dose methotrexate level in Egyptian Pediatric Acute Lymphoblastic Leukemia patients: Children's Cancer Hospital-Egypt [CCHE] Experience
    Rashed, W.
    Hamdy, N.
    [J]. EUROPEAN JOURNAL OF CANCER, 2013, 49 : S358 - S358
  • [27] Metabolic response as assessed by 18F-fluorodeoxyglucose positron emission tomography-computed tomography does not predict outcome in patients with intermediate- or high-risk rhabdomyosarcoma: A report from the Children's Oncology Group Soft Tissue Sarcoma Committee
    Harrison, Douglas J.
    Chi, Yueh-Yun
    Tian, Jing
    Hingorani, Pooja
    Mascarenhas, Leo
    McCowage, Geoffrey B.
    Weigel, Brenda J.
    Venkatramani, Rajkumar
    Wolden, Suzanne L.
    Yock, Torunn I.
    Rodeberg, David A.
    Hayes-Jordan, Andrea A.
    Teot, Lisa A.
    Spunt, Sheri L.
    Meyer, William H.
    Hawkins, Douglas S.
    Shulkin, Barry L.
    Parisi, Marguerite T.
    [J]. CANCER MEDICINE, 2021, 10 (03): : 857 - 866
  • [28] Anti-Pegaspargase, Anti-Calaspargase Pegol, and Anti-Polyethelene Glycol Antibody Incidence in High Risk Acute Lymphoblastic Leukemia Patients Receiving Pegaspargase or Calaspargase Pegol and Associated Anaphylactic or Hypersensitivity Reaction Rates: Results from Children's Oncology Group (COG) Study AALL07P4
    Schore, Reuven J.
    Devidas, Meenakshi
    Bleyer, Archie
    Reaman, Gregory
    Lebedinsky, Claudia
    Zhang, Hui
    Koppensteiner, Herwig
    Loh, Mignon L.
    Raetz, Elizabeth
    Winick, Naomi
    Carroll, William L.
    Hunger, Stephen P.
    Angiolillo, Anne
    [J]. BLOOD, 2016, 128 (22)